[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Filters

Search
Categories
1,980
407
176
Publishers
2,563
Regions
Price
Date
Pages
Offers

DelveInsight: Market Research Reports

DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
  • Company’s profile and licensing data;
  • New technology studies;
  • Biologic benchmarking;
  • Treatment modality analysis;
  • Competitive landscape;
  • Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.

DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.

Publications found: 2,563
Sort by:
Tinnitus - Pipeline Insight, 2019 US$ 1,000.00

... clients within 48 Hours 'Tinnitus - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Tinnitus development. The report provides detailed ...

October 2019 60 pages
Fanconi Anemia (FA) - Pipeline Insight, 2019 US$ 1,000.00

October 2019 60 pages
Hallux Valgus - Pipeline Insight, 2019 US$ 1,000.00

October 2019 60 pages
Ichthyosis- Pipeline Insight, 2019 US$ 1,000.00

October 2019 60 pages
Keratoconus - Pipeline Insight, 2019 US$ 1,000.00

October 2019 60 pages
Lichen Planus - Pipeline Insight, 2019 US$ 1,000.00

October 2019 60 pages
Opioid Overdose - Pipeline Insight, 2019 US$ 1,000.00

October 2019 60 pages
Pheochromocytoma - Pipeline Insight, 2019 US$ 1,000.00

October 2019 60 pages
Sialorrhea- Pipeline Insight, 2019 US$ 1,000.00

October 2019 60 pages
Tay-Sachs Disease - Pipeline Insight, 2019 US$ 1,000.00

October 2019 60 pages
Varicose Ulcer - Pipeline Insight, 2019 US$ 1,000.00

October 2019 60 pages
Vaso-Occlusive Crisis - Pipeline Insight, 2019 US$ 1,000.00

October 2019 60 pages
Wilms Tumor - Pipeline Insight, 2019 US$ 1,000.00

October 2019 60 pages
Uveitis- Market Insights, Epidemiology, and Market Forecast-2028 US$ 5,000.00

... . Uveitis Report Insights Patient Population Therapeutic Approaches Pipeline Analysis Market Size and Trends Market Opportunities Impact of upcoming Therapies Uveitis Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs ...

September 2019 237 pages
Alpha- Antitrypsin Deficiency (AATD) - Epidemiology Forecast-2028 US$ 2,600.00

... UK) Patient Population in various epidemiological segments Population at risk of AATD Prevalent Population of AATD Diagnosed Prevalence of AATD Gender Specific case of AATD Comorbidities associated with AATD Therapeutic Approaches Alpha- Antitrypsin Deficiency (AATD) Report Key Strengths 10 Year Forecast 6MM ...

September 2019 100 pages
Uveitis - Epidemiology Forecast-2028 US$ 2,600.00

... be delivered to the clients within 24 hours DelveInsight’s ‘Uveitis - Epidemiology Forecast-2028’ report deliver an in-depth understanding of the disease, historical & forecasted epidemiology trends of Uveitis in the United States, EU5 (Germany, Spain ...

September 2019 100 pages
Neuroendocrine Tumors (NETs)- Epidemiology Forecast to 2028 US$ 2,600.00

... patient population The report provides the segmentation of the disease epidemiology by total prevalent population, total incident population, total diagnosed prevalent cases of Neuroendocrine Tumors, symptom based classification, diagnosed prevalent cased based on malignancy, site-specific prevalent ...

September 2019 100 pages
Neuroendocrine Tumors (NETs) - Market Insights, Epidemiology and Market Forecast-2028 US$ 5,000.00

... . Neuroendocrine Tumors Report Insights Patient Population Therapeutic Approaches Pipeline Analysis Market Size and Trends Market Opportunities Impact of upcoming Therapies Neuroendocrine Tumors Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs ...

September 2019 266 pages
Spinocerebellar Ataxia (SCA) - Market Insights, Epidemiology and Market Forecast-2028 US$ 5,000.00

... . Spinocerebellar Ataxia Report Insights Patient Population Therapeutic Approaches Pipeline Analysis Market Size and Trends Market Opportunities Impact of upcoming Therapies Spinocerebellar Ataxia Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs ...

September 2019 118 pages
Cystinuria- Market Insights, Epidemiology, and Market Forecast-2028 US$ 5,000.00

... 2017–2028 Cystinuria - Disease Understanding and Treatment Algorithm Cystinuria is an autosomal ... Pipeline Analysis Market Size and Trends Market Opportunities Impact of upcoming Therapies Cystinuria Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market ...

September 2019 145 pages
Alpha- Antitrypsin Deficiency (AATD) - Market Insights, Epidemiology and Market Forecast-2028 US$ 5,000.00

... . Alpha- Antitrypsin Deficiency (AATD) Report Insights Patient Population Therapeutic Approaches Pipeline Analysis Market Size and Trends Market Opportunities Impact of upcoming Therapies Alpha- Antitrypsin Deficiency (AATD) Report Key Strengths 10 Year Forecast 6MM Coverage Epidemiology Segmentation Drugs ...

September 2019 146 pages
Catheter-Related Bloodstream Infections (CRBSIs)- Epidemiology Forecast-2028 US$ 2,600.00

... 10 Year Forecast of Catheter-related Bloodstream Infections epidemiology 7MM Coverage Total Incident Population of CRBSI Total Diagnosed Incident Population of CRBSI Diagnosed Incidence of CRBSI by Causative Pathogens Catheter-related Bloodstream Infections Report Assessment Patient Segmentation Disease Risk ...

September 2019 100 pages
Catheter-Related Bloodstream Infections (CRBSIs)- Market Insights, Epidemiology, and Market Forecast-2028 US$ 5,000.00

... -related Bloodstream Infections Report Insights Patient Population Therapeutic Approaches Pipeline Analysis Market Size and Trends Market Opportunities Impact of upcoming Therapies Catheter-related Bloodstream Infections Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs ...

September 2019 187 pages
Cystinuria- Epidemiology Forecast-2028 US$ 2,600.00

... the diagnosed patient pool and their trends along with assumptions undertaken. The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (Total Prevalence of Cystinuria in 7MM ...

September 2019 87 pages
Hepatic Encephalopathy- Epidemiology Forecast-2028 US$ 2,600.00

... diagnosed patient pool and their trends along with assumptions undertaken. The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (Total Prevalence of Hepatic Encephalopathy in 7MM, Total Diagnosed Prevalence of Hepatic Encephalopathy ...

September 2019 80 pages
Hepatic Encephalopathy- Market Insights, Epidemiology, and Market Forecast-2028 US$ 5,000.00

... . Hepatic Encephalopathy Report Insights Patient Population Therapeutic Approaches Pipeline Analysis Market Size and Trends Market Opportunities Impact of upcoming Therapies Hepatic Encephalopathy Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs ...

September 2019 160 pages
Hormone Receptor (HR)-positive/ Human Epidermal Receptor 2 (HER2)-negative Breast Cancer- Epidemiology Forecast–2028 US$ 2,600.00

... ’s ‘Hormone Receptor (HR)-positive/Human Epidermal Receptor 2 (HER2)-negative Breast Cancer- Epidemiology Forecast–2028 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Hormone Receptor (HR)-positive/Human Epidermal Receptor 2 (HER2)-negative Breast ...

September 2019 100 pages
Hormone Receptor (HR)-positive/ Human Epidermal Receptor 2 (HER2)-negative Breast Cancer- Market Insights, Epidemiology and Market Forecast–2028 US$ 5,000.00

... Hormone Receptor (HR)-positive/Human Epidermal Receptor 2 (HER2)-negative Breast Cancer- Market Insights, Epidemiology and Market Forecast–2028 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology as well as the market trends of Hormone Receptor (HR)-positive/Human ...

September 2019 360 pages
Spinocerebellar Ataxia (SCA)- Epidemiology Forecast to 2028 US$ 2,600.00

... patient population The report provides the segmentation of the disease epidemiology by prevalence of SCA, total diagnosed prevalence of Spinocerebellar Ataxia, incidence of Spinocerebellar Ataxia, and type-specific prevalent cases in 7MM Key strengths 10 Year Forecast of Spinocerebellar Ataxia epidemiology ...

September 2019 80 pages
Carcinoid Syndrome- Pipeline Insight, 2019 US$ 1,250.00

... Carcinoid Syndrome- Pipeline Insight, 2019" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the indication. A detailed picture of the Carcinoid Syndrome pipeline ... 's proprietary databases, company/university websites, clinical trial registries, conferences, ...

August 2019 60 pages
Chagas Disease - Pipeline Insight, 2019 US$ 1,250.00

... Chagas Disease pipeline landscape is provided which includes the disease overview and Chagas Disease treatment guidelines. The assessment part of the report embraces, in depth Chagas Disease commercial assessment and clinical ...

August 2019 60 pages
Chronic Neuropathic Pain (CNP) - Pipeline Insight, 2019 US$ 1,250.00

... disease overview and Chronic Neuropathic Pain treatment guidelines. The assessment part of the report embraces, in depth Chronic Neuropathic Pain commercial assessment and clinical assessment of the pipeline products under ...

August 2019 60 pages
Gorlin Syndrome - Pipeline Insight, 2019 US$ 1,250.00

... Gorlin Syndrome treatment guidelines. The assessment part of the report embraces, in depth Gorlin Syndrome commercial assessment and clinical assessment of the pipeline ... traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor ...

August 2019 60 pages
Graves’ Ophthalmopathy - Pipeline Insight, 2019 US$ 1,250.00

... Graves’ Ophthalmopathy Pipeline Development Activities The report provides insights into different therapeutic candidates in discovery and preclinical, phase 1, phase 2, and phase 3 stage. Drugs ... researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC ...

August 2019 60 pages
Hypoactive Sexual Desire Disorder (HSDD) - Pipeline Insight, 2019 US$ 1,250.00

... therapy (which has been the standard treatment for HSDD for a long time), Testosterone treatment (Menopausal women with HSDD). Hypoactive Sexual Desire Disorder (HSDD) Pipeline ... from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, ...

August 2019 60 pages
Hypothalamic Obesity (HO) - Pipeline Insight, 2019 US$ 1,250.00

... Hypothalamic Obesity treatment guidelines. The assessment part of the report embraces, in depth Hypothalamic Obesity commercial assessment and clinical assessment of the pipeline ... from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, ...

August 2019 60 pages
Idiopathic CD4+ Lymphocytopenia - Pipeline Insight, 2019 US$ 1,250.00

... disease overview and Idiopathic CD4+ Lymphocytopenia treatment guidelines. The assessment part of the report embraces, in depth Idiopathic CD4+ Lymphocytopenia commercial assessment and clinical assessment of the pipeline products under ...

August 2019 60 pages
Lactose Intolerance - Pipeline Insight, 2019 US$ 1,250.00

... Lactose malassimilation. Lactose Intolerance Pipeline Development Activities The report provides insights into different therapeutic candidates in discovery and preclinical, phase 1, phase 2, and phase 3 stage. Drugs ... proprietary databases, company/university websites, clinical trial registries, conferences, ...

August 2019 60 pages
Lambert-Eaton Myasthenic Syndrome (LEMS)- Pipeline Insight, 2019 US$ 1,250.00

... disease overview and Lambert-Eaton Myasthenic Syndrome (LEMS) treatment guidelines. The assessment part of the report embraces, in depth Lambert-Eaton Myasthenic Syndrome (LEMS) commercial assessment and clinical assessment of the pipeline products under ...

August 2019 60 pages
Phosphoglucomutase (PGM 1) Deficiency- Pipeline Insight, 2019 US$ 1,250.00

... report which includes Company-Company Collaborations (Licensing / Partnering), Company-Academia Collaborations, and Acquisition analysis in both Graphical and tabulated form. Phosphoglucomutase (PGM 1) Deficiency Clinical Assessment of products ...

August 2019 60 pages
Post-Transplant Lymphoproliferative Disorder- Pipeline Insight, 2019 US$ 1,250.00

... post-transplant lymphoproliferative disease. Early diagnosis and prompt treatment of these disorders are extremely important. Post-Transplant Lymphoproliferative Disorder Pipeline Development Activities The report provides insights ... databases, company/university websites, clinical trial registries, conferences ...

August 2019 60 pages
Primary Biliary Cholangitis - Pipeline Insight, 2019 US$ 1,250.00

... disease overview and Primary Biliary Cholangitis treatment guidelines. The assessment part of the report embraces, in depth Primary Biliary Cholangitis commercial assessment and clinical assessment of the pipeline products under ...

August 2019 60 pages
Primary Progressive Aphasia - Pipeline Insight, 2019 US$ 1,250.00

... disease overview and Primary Progressive Aphasia treatment guidelines. The assessment part of the report embraces, in depth Primary Progressive Aphasia commercial assessment and clinical assessment of the pipeline products under ...

August 2019 60 pages